The authors sought to identify mRNA biomarkers of cerebral vasospasm in whole blood of patients suffering from aneurysmal subarachnoid hemorrhage (aSAH).
A prospective transcriptomic study for vasospasm was conducted in whole blood samples of 44 aSAH patients who developed (VSP+ group, n = 22) or did not develop (VSP− group, n = 22) vasospasm. Samples from all patients were profiled for 21,460 mRNA probes using the Illumina Human HT12v4.0 array. Differential statistical analysis was performed using a linear mixed model.
Levels of sphingosine-1-phosphate receptor 4 (S1PR4) mRNA were significantly higher (p = 8.03 × 10−6) at presentation in patients who developed vasospasm after aSAH than in patients who did not.
The results, which are consistent with findings of previous experimental investigations conducted in animal models, support the role of S1PR4 and its ligand, sphingosine-1-phosphate (S1P), in arterial-associated vasoconstriction, which suggests that S1PR4 could be used as a biomarker for cerebral vasospasm in aSAH patients.
ABBREVIATIONSaSAH = aneurysmal subarachnoid hemorrhage; D0 = day of admission; Dv3 = 3 days before the day VSP+ patients experienced vasospasm (or the corresponding day for the matched VSP− patients); miRNA = microRNA; S1P = sphingosine-1-phosphate; S1PR4 = sphingosine-1-phosphate receptor 4; TCD = transcranial Doppler; VSP = vasospasm patient group.
Correspondence David-Alexandre Trégouët: INSERM UMR_S 1219, Bordeaux Population Health Research Center, Bordeaux, France. firstname.lastname@example.org.INCLUDE WHEN CITING Published online November 29, 2019; DOI: 10.3171/2019.9.JNS191305.
V.D. and D.A.T. contributed equally to this work.
Disclosures Dr. Clarençon reports personal and consultant or advisory relationships, including paid lectures, with Balt, Medtronic, and Penumbra.